InSysBio to present its ePoster at ECTRIMS 2022

events
Conference
October 25, 2022

October 25, 2022

InSysBio team is going to present its poster in frames of the 38th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS 2022) which is to be held October 26-28, Amsterdam, the Netherlands. The ePoster is going to be presented in frames of "Pathology and pathogenesis of MS - Neurodegeneration" ePoster Area, October 26, 08:00 - 08:00 CEST:

  • EP0960 (10) - "Neurodegeneration quantitative systems pharmacology modelling for analysis of multiple sclerosis therapy" by Polina Pchelintseva1, Anna Mishina1, Tatiana Karelina2

Affiliation: (1) InSysBio, Moscow, Russia; (2) InSysBio CY, Paphos, Cyprus

 

About InSysBio

InSysBio is a Quantitative Systems Pharmacology (QSP) company located in Edinburgh, UK (INSYSBIO UK LIMITED), Cyprus (INSYSBIO CY Ltd) and Moscow, Russia (INSYSBIO LLC). InSysBio was founded in 2004 and has an extensive track record of helping pharmaceutical companies to make right decisions on the critical stages of drug research and development by application of QSP modeling. InSysBio’s innovative QSP approach has already become a part of the drug development process implemented by our strategic partners: there are more than 100 completed projects in collaboration with leaders of pharmaceutical industry. For more information about InSysBio, its solutions and services, visit www.insysbio.com.

March 2025
MoTuWeThFrSaSu
     
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
1. 19 Mar 2025 15:40 The project aims at mechanistic modeling of antibodies to predict pharmacokinetics and target occupancy in cerebrospinal fluid InSysBio, one of the world’s pioneers of Quantitative Systems Pharmacology (QSP) modeling, announces its collaboration with discoveric bio alpha, a biotechnology company taking next generation antibody technologies into Alzheimer’s Disease
20
21
22
23
24
25
26
1. 26 Mar 2025 00:12 InSysBio to participate in AACR 2025 InSysBio announces its participation in AACR Annual Meeting 2025 which is to be held from April 25-30, 2025, at McCormick Place Convention Center, Chicago, Illinois, USA. InSysBio team is going to present their QSP modeling services and software to optimize drug development at Booth #4845 and 3 posters in frames of the Meeting
27
28
29
30
31
1. 31 Mar 2025 15:17 Now the Immunological Synapse submodels are meaningfully improved InSysBio launches Immune Response Template (IRT) version 3.7.0. IRT represents a QSP platform of immune system, simultaneously, being a tool for development of models related to immune system. IRT v.3.7.0 gets a range of new features.
      
Upcoming Events
25.04
InSysBio to participate in AACR 2025
Tags
Latest News
31.03
InSysBio to launch Immune Response Template version 3.7.0 for QSP modeling
19.03
InSysBio announces its collaboration with discoveric bio alpha
19.02
InSysBio to publish the new article in CPT: Pharmacometrics & Systems Pharmacology
05.12
InSysBio to celebrate its 20-year anniversary
10.09
InSysBio team to publish the new article in PSPJournal